. 2017 Sep 19;2017:7648505. doi: 10.1155/2017/7648505

Table 2.

Effects of COE on FBG in diabetic model mice with time.

Groups	FBG (mmol/L)
Groups	W0	W1	W2	W3	W4
NC	6.20 ± 0.19^∗∗	6.60 ± 0.25^∗∗	7.05 ± 0.86^∗∗^#	6.21 ± 0.71^∗∗	6.44 ± 0.58^∗∗
DM	22.03 ± 2.78^ΔΔ	22.30 ± 2.12^ΔΔ	26.71 ± 2.20^ΔΔ##	28.73 ± 2.92^ΔΔ##	27.71 ± 2.74^ΔΔ##
COE-L	22.28 ± 4.20^ΔΔ	17.16 ± 2.45^∗∗^ΔΔ#	17.99 ± 1.44^∗∗^ΔΔ#	23.09 ± 1.43^∗∗^ΔΔ	20.61 ± 4.05^∗∗^ΔΔ
COE-H	21.46 ± 5.22^ΔΔ	15.36 ± 3.92^∗∗^ΔΔ##	14.74 ± 1.23^∗∗^ΔΔ##	18.31 ± 2.81^∗∗^ΔΔ	17.18 ± 2.78^∗∗^ΔΔ
ROS	21.01 ± 2.89^ΔΔ	16.08 ± 3.90^∗∗^ΔΔ##	17.71 ± 3.42^∗∗^ΔΔ	20.46 ± 2.78^∗∗^ΔΔ	17.74 ± 2.34^∗∗^ΔΔ

Data were presented as mean ± standard deviation (n = 8). FBG: fast blood glucose level. FBG of each group was determined weekly at the initiation of treatment (W0), one week after treatment (W1), two weeks after treatment (W2), three weeks after treatment (W3), and four weeks after treatment (W4). ^∗∗P < 0.01 compared to group DM; ^ΔΔP < 0.01 compared to group NC; ^#P < 0.05 and ^##P < 0.01 compared to W0.